Gusenleitner, Daniel
Dana-Farber Cancer Institute
3 papers on CoChatORCID 0000-0002-7428-0880
Most cited papers
- Verified
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
Rodig, S. J., Gusenleitner, D., Jackson, D. G., Gjini, E., Giobbie-Hurder, A., Jin, C., Chang, H., Lovitch, S. B., Horak, C., Weber, J. S., et al. (2018) · Science Translational Medicine
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 579
- Verified
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
Subrahmanyam, P. B., Dong, Z., Gusenleitner, D., Giobbie-Hurder, A., Severgnini, M., Zhou, J., Manos, M., Eastman, L. M., Maecker, H. T., & Hodi, F. S. (2018) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 190
- Verified
An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER−/PR−/Her2− Human Breast Cancer Cells
Novikov, O., Wang, Z., Stanford, E. A., Parks, A. J., Ramirez-Cardenas, A., Landesman, E., Laklouk, I., Sarita-Reyes, C., Gusenleitner, D., Li, A., et al. (2016) · Molecular Pharmacology
Toxic Organic Pollutants ImpactTryptophan and brain disorders
Cited by 167
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free